Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis
| Autor: | Antonis Halapas, Dimitrios Karamanolakis, Andreas Papaioannou, Nicholas Pissimissis, Theodore Dimopoulos, Antigone Sourla, Peter Lembessis, John Bogdanos, Constantine Milathianakis, Michael Koutsilieris |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
medicine.medical_specialty Antineoplastic Agents Hormonal medicine.drug_class Urology medicine.medical_treatment Bone Neoplasms Dexamethasone Gonadotropin-Releasing Hormone Prostate cancer medicine Humans Gynecology business.industry Prostatic Neoplasms Bone metastasis Androgen Antagonists Androgen medicine.disease Somatostatin Hormone therapy Luteinizing hormone business medicine.drug Hormone |
| Zdroj: | BJU International. 100:60-62 |
| ISSN: | 1464-410X 1464-4096 |
| DOI: | 10.1111/j.1464-410x.2007.06958.x |
| Popis: | Michael Koutsilieris, Theodore Dimopoulos*, Constantine Milathianakis†, John Bogdanos, Dimitrios Karamanolakis, Nicholas Pissimissis, Antonis Halapas, Peter Lembessis, Andreas Papaioannou‡ and Antigone Sourla¶ Department of Experimental Physiology, Medical School, National & Kapodistrian University of Athens, Goudi-Athens, *Urology Clinic, Panagia General Hospital, Thessaloniki, †Urology Clinic, ‘Metaxa’ Anticancer Hospital, Piraeus, ‡Urology Clinic, Argos General Hospital, Argos, and ¶Endo/OncoResearch Laboratories, Diagnostic Medical Center, Athens, Greece |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|